Insider Buy/Sell Details for the Healthcare Sector — June 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1771)
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
112,299
Price
$120.66
Total Value
$13.55M
Shares Held After
2,963,607
% of Holdings
3.7%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
37,179
Price
$119.71
Total Value
$4.45M
Shares Held After
3,075,906
% of Holdings
1.2%
Trulieve Cannabis Corp. (TRLV)
Rivers Kim A. — Director
Shares
300,000
Price
$8.17
Total Value
$2.45M
Shares Held After
1,613,724
% of Holdings
15.7%
Nurix Therapeutics, Inc. (NRIX)
Hansen Gwenn — Chief Scientific Officer
Shares
5,394
Price
$20.00
Total Value
$107.88K
Shares Held After
115,005
% of Holdings
4.5%
Nurix Therapeutics, Inc. (NRIX)
Ring Christine — Chief Legal Officer
Shares
28,935
Price
$20.06
Total Value
$580.51K
Shares Held After
13,579
% of Holdings
68.1%
Kymera Therapeutics, Inc. (KYMR)
Goodman Noah — Chief Business Officer
Shares
2,500
Price
$119.00
Total Value
$297.50K
Shares Held After
50,195
% of Holdings
4.7%
Kymera Therapeutics, Inc. (KYMR)
Goodman Noah — Chief Business Officer
Shares
2,500
Price
$109.00
Total Value
$272.50K
Shares Held After
52,695
% of Holdings
4.5%
908 Devices Inc. (MASS)
Knopp Kevin J. — Director
Shares
16,388
Price
$9.10
Total Value
$149.13K
Shares Held After
735,623
% of Holdings
2.2%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
19,973
Price
$21.02
Total Value
$419.83K
Shares Held After
1,086,063
% of Holdings
1.8%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
25,397
Price
$21.02
Total Value
$533.84K
Shares Held After
1,484,760
% of Holdings
1.7%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
50,530
Price
$21.02
Total Value
$1.06M
Shares Held After
4,755,109
% of Holdings
1.1%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
2,029
Price
$101.14
Total Value
$205.21K
Shares Held After
597,047
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
14,490
Price
$101.14
Total Value
$1.47M
Shares Held After
3,343,343
% of Holdings
0.4%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
14,513
Price
$100.42
Total Value
$1.46M
Shares Held After
599,076
% of Holdings
2.4%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
103,688
Price
$100.42
Total Value
$10.41M
Shares Held After
3,357,833
% of Holdings
3.0%
Trulieve Cannabis Corp. (TRLV)
Rivers Kim A. — Director
Shares
400,000
Price
$8.17
Total Value
$3.27M
Shares Held After
1,913,724
% of Holdings
17.3%
908 Devices Inc. (MASS)
Knopp Kevin J. — Director
Shares
40,535
Price
$9.14
Total Value
$370.49K
Shares Held After
752,011
% of Holdings
5.1%
Royalty Pharma plc (RPRX)
Urist Marshall — EVP, Research & Investments
Shares
9,098
Price
$55.18
Total Value
$502.07K
Shares Held After
9,099
% of Holdings
50.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$553.24
Total Value
$221.30K
Shares Held After
40,513
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
360
Price
$551.76
Total Value
$198.64K
Shares Held After
40,913
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,003
Price
$551.03
Total Value
$552.68K
Shares Held After
41,273
% of Holdings
2.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,357
Price
$550.06
Total Value
$746.43K
Shares Held After
42,276
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,300
Price
$548.74
Total Value
$713.36K
Shares Held After
43,633
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,086
Price
$548.01
Total Value
$1.14M
Shares Held After
44,933
% of Holdings
4.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,234
Price
$547.03
Total Value
$1.22M
Shares Held After
47,019
% of Holdings
4.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
760
Price
$545.93
Total Value
$414.90K
Shares Held After
49,253
% of Holdings
1.5%
CG Oncology, Inc. (CGON)
POST LEONARD E — Director
Shares
5,000
Price
$70.00
Total Value
$350.00K
Shares Held After
0
% of Holdings
100.0%
Beta Bionics, Inc. (BBNX)
Hopman Mark — Chief Commercial Officer
Shares
1,258
Price
$15.01
Total Value
$18.88K
Shares Held After
129,354
% of Holdings
1.0%
Lite Strategy, Inc. (LITS)
Flynn James P — Director
Shares
25,000
Price
$0.86
Total Value
$21.39K
Shares Held After
125,000
% of Holdings
20.0%
Beta Bionics, Inc. (BBNX)
Jones Christy — Director
Shares
1,406
Price
$15.00
Total Value
$21.09K
Shares Held After
25,994
% of Holdings
5.1%
Monte Rosa Therapeutics, Inc. (GLUE)
Janku Filip — Chief Medical Officer
Shares
30,000
Price
$21.42
Total Value
$642.68K
Shares Held After
59,992
% of Holdings
33.3%
BECTON DICKINSON & CO (BDX)
Garrison Michael David — EVP & Pres Med.Essntl&BioPharm
Shares
1,100
Price
$145.66
Total Value
$160.23K
Shares Held After
13,172
% of Holdings
7.7%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
23,067
Price
$71.67
Total Value
$1.65M
Shares Held After
0
% of Holdings
100.0%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
119,244
Price
$71.67
Total Value
$8.55M
Shares Held After
0
% of Holdings
100.0%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
3,460
Price
$71.67
Total Value
$247.97K
Shares Held After
0
% of Holdings
100.0%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
145,417
Price
$71.67
Total Value
$10.42M
Shares Held After
0
% of Holdings
100.0%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
19,173
Price
$70.84
Total Value
$1.36M
Shares Held After
23,067
% of Holdings
45.4%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
99,118
Price
$70.84
Total Value
$7.02M
Shares Held After
119,244
% of Holdings
45.4%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
2,876
Price
$70.84
Total Value
$203.72K
Shares Held After
3,460
% of Holdings
45.4%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
120,873
Price
$70.84
Total Value
$8.56M
Shares Held After
145,417
% of Holdings
45.4%
Oncotelic Therapeutics, Inc. (OTLC)
Trieu Vuong — Director
Shares
115,000
Price
$0.04
Total Value
$5.17K
Shares Held After
93,884,319
% of Holdings
0.1%
CAPRICOR THERAPEUTICS, INC. (CAPR)
Bergmann Anthony — CHIEF FINANCIAL OFFICER
Shares
400
Price
$30.00
Total Value
$12.00K
Shares Held After
11,223
% of Holdings
3.4%
CAPRICOR THERAPEUTICS, INC. (CAPR)
Krasney Karen — EVP, GENERAL COUNSEL
Shares
400
Price
$30.00
Total Value
$12.00K
Shares Held After
30,547
% of Holdings
1.3%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
114
Price
$14.98
Total Value
$1.71K
Shares Held After
169,556
% of Holdings
0.1%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
6,979
Price
$14.60
Total Value
$101.89K
Shares Held After
169,670
% of Holdings
4.0%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
666
Price
$14.98
Total Value
$9.98K
Shares Held After
793,328
% of Holdings
0.1%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
40,679
Price
$14.60
Total Value
$593.91K
Shares Held After
793,994
% of Holdings
4.9%
BridgeBio Pharma, Inc. (BBIO)
Cook Jennifer E. — Director
Shares
37,167
Price
$70.00
Total Value
$2.60M
Shares Held After
8,383
% of Holdings
81.6%
Arcus Biosciences, Inc. (RCUS)
Jaen Juan C. — President
Shares
6,431
Price
$29.66
Total Value
$190.74K
Shares Held After
890,809
% of Holdings
0.7%
ARVINAS, INC. (ARVN)
Saik Andrew — Chief Financial Officer
Shares
5,696
Price
$8.16
Total Value
$46.47K
Shares Held After
187,432
% of Holdings
2.9%
Showing 51–100 of 1771 transactions (page 2 of 36)